Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
La Revue Du Praticien
|
April 16, 2019
[Canal anal carcinoma]
Nabil Baba-Hamed, Alix Portal
Clinics and Research in Hepatology and Gastroenterology
|
February 25, 2014
Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy
Alix Portal, Simon Pernot, Nathalie Siauve, et al.
Transplantation
|
March 22, 2018
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study
Vincent Mallet, Rebecca Sberro-Soussan, Anne-Marie Roque-Afonso, et al.
British Journal of Cancer
|
September 16, 2015
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
Alix Portal, Simon Pernot, David Tougeron, et al.
The Oncologist
|
June 14, 2025
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study
Camille Evrard, Antoine Pelras, Simon Rivet, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
La Revue Du Praticien
|
April 16, 2019
[Canal anal carcinoma]
Nabil Baba-Hamed, Alix Portal
Clinics and Research in Hepatology and Gastroenterology
|
February 25, 2014
Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy
Alix Portal, Simon Pernot, Nathalie Siauve, et al.
Transplantation
|
March 22, 2018
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study
Vincent Mallet, Rebecca Sberro-Soussan, Anne-Marie Roque-Afonso, et al.
British Journal of Cancer
|
September 16, 2015
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
Alix Portal, Simon Pernot, David Tougeron, et al.
The Oncologist
|
June 14, 2025
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study
Camille Evrard, Antoine Pelras, Simon Rivet, et al.
Page
of 1